Skin thickness, estrogen use, and bone mass in older women

Study of Osteoporotic Fractures Research Group

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

To test the hypothesis that estrogen replacement therapy preserves skin thickness, and to determine the relationship between bone mass and skin thickness, we performed a cross-sectional analysis of baseline data collected for a multicenter prospective study of osteoporotic fractures. 1,072 ambulatory nonblack women aged 65 years or older were recruited from population-based listings at two US clinical centers. Demographic and historical information and anthropometric measurements were obtained from a baseline questionnaire, interview, and examination. Estrogen use was assessed by questionnaire and interview. Skin thickness was measured over the middle metacarpophalangeal joint with mechanical calipers. Bone mass was measured by single photon absorptiometry at three appendicular sites: The distal and midradius, and the calcaneus. After adjusting for other potential confounding factors, each 10 years of age was associated with an 8.6% reduction in skin thickness, and every 5-kg/m2increase in body mass index was associated with a 3.8% increase in skin thickness. Smokers had thinner skin than nonsmokers. Estrogen users had thinner skin; compared to never-users, current users had a 5.1% reduction in skin thickness, and past users had a 2.0% reduction in skin thickness. Among estrogen users, every 10 years of use was associated with a 1.7% reduction in skin thickness. Skin thickness was weakly associated with bone mass of the middle radius and calcaneus, but not the distal radius. We found no evidence that estrogen preserves skin thickness; indeed, estrogen use is associated with thinner skin. Although skin thickness and bone mass are related, the association is too weak to be useful for predicting bone mass.

Original languageEnglish (US)
Pages (from-to)131-136
Number of pages6
JournalMenopause
Volume1
Issue number3
StatePublished - 1994
Externally publishedYes

Fingerprint

Estrogens
Bone and Bones
Skin
Calcaneus
Interviews
Metacarpophalangeal Joint
Osteoporotic Fractures
Estrogen Replacement Therapy
Photon Absorptiometry
Multicenter Studies
Body Mass Index
Cross-Sectional Studies
Demography
Prospective Studies

Keywords

  • Bone mineral density
  • Estrogen replacement therapy
  • Skin thickness

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Study of Osteoporotic Fractures Research Group (1994). Skin thickness, estrogen use, and bone mass in older women. Menopause, 1(3), 131-136.

Skin thickness, estrogen use, and bone mass in older women. / Study of Osteoporotic Fractures Research Group.

In: Menopause, Vol. 1, No. 3, 1994, p. 131-136.

Research output: Contribution to journalArticle

Study of Osteoporotic Fractures Research Group 1994, 'Skin thickness, estrogen use, and bone mass in older women', Menopause, vol. 1, no. 3, pp. 131-136.
Study of Osteoporotic Fractures Research Group. Skin thickness, estrogen use, and bone mass in older women. Menopause. 1994;1(3):131-136.
Study of Osteoporotic Fractures Research Group. / Skin thickness, estrogen use, and bone mass in older women. In: Menopause. 1994 ; Vol. 1, No. 3. pp. 131-136.
@article{6f76e85ebb474c27a58b9af5fd04812d,
title = "Skin thickness, estrogen use, and bone mass in older women",
abstract = "To test the hypothesis that estrogen replacement therapy preserves skin thickness, and to determine the relationship between bone mass and skin thickness, we performed a cross-sectional analysis of baseline data collected for a multicenter prospective study of osteoporotic fractures. 1,072 ambulatory nonblack women aged 65 years or older were recruited from population-based listings at two US clinical centers. Demographic and historical information and anthropometric measurements were obtained from a baseline questionnaire, interview, and examination. Estrogen use was assessed by questionnaire and interview. Skin thickness was measured over the middle metacarpophalangeal joint with mechanical calipers. Bone mass was measured by single photon absorptiometry at three appendicular sites: The distal and midradius, and the calcaneus. After adjusting for other potential confounding factors, each 10 years of age was associated with an 8.6{\%} reduction in skin thickness, and every 5-kg/m2increase in body mass index was associated with a 3.8{\%} increase in skin thickness. Smokers had thinner skin than nonsmokers. Estrogen users had thinner skin; compared to never-users, current users had a 5.1{\%} reduction in skin thickness, and past users had a 2.0{\%} reduction in skin thickness. Among estrogen users, every 10 years of use was associated with a 1.7{\%} reduction in skin thickness. Skin thickness was weakly associated with bone mass of the middle radius and calcaneus, but not the distal radius. We found no evidence that estrogen preserves skin thickness; indeed, estrogen use is associated with thinner skin. Although skin thickness and bone mass are related, the association is too weak to be useful for predicting bone mass.",
keywords = "Bone mineral density, Estrogen replacement therapy, Skin thickness",
author = "{Study of Osteoporotic Fractures Research Group} and Bauer, {Douglas C.} and Deborah Grady and Alice Pressman and Cummings, {R. S.} and Nevitt, {C. M.} and D. Black and Genant, {K. H.} and C. Arnaud and W. Browner and L. Christianson and M. Dockrell and C. Fox and C. Gluer and S. Harvey and M. Jergas and L. Palermo and A. Pressman and {San Valentin}, R. and D. Seeley and P. Steiger and K. Stone and R. Sherwin and J. Scott and K. Fox and J. Lewis and G. Greenberg and M. Bahr and S. Trusty and L. Finazzo and S. Snyder and E. Oliner and B. Hohman and T. Page and K. Ensrud and R. Grimm and C. Bell and E. Mitson and I. Chavier and K. Jacobson and S. Fill-houer and C. Shoberg and D. Michel and S. Estill and J. Hansen and M. Baumhover and Cauley, {A. J.} and Kuller, {H. L.} and L. Harper and M. Nasim and Eric Orwoll",
year = "1994",
language = "English (US)",
volume = "1",
pages = "131--136",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Skin thickness, estrogen use, and bone mass in older women

AU - Study of Osteoporotic Fractures Research Group

AU - Bauer, Douglas C.

AU - Grady, Deborah

AU - Pressman, Alice

AU - Cummings, R. S.

AU - Nevitt, C. M.

AU - Black, D.

AU - Genant, K. H.

AU - Arnaud, C.

AU - Browner, W.

AU - Christianson, L.

AU - Dockrell, M.

AU - Fox, C.

AU - Gluer, C.

AU - Harvey, S.

AU - Jergas, M.

AU - Palermo, L.

AU - Pressman, A.

AU - San Valentin, R.

AU - Seeley, D.

AU - Steiger, P.

AU - Stone, K.

AU - Sherwin, R.

AU - Scott, J.

AU - Fox, K.

AU - Lewis, J.

AU - Greenberg, G.

AU - Bahr, M.

AU - Trusty, S.

AU - Finazzo, L.

AU - Snyder, S.

AU - Oliner, E.

AU - Hohman, B.

AU - Page, T.

AU - Ensrud, K.

AU - Grimm, R.

AU - Bell, C.

AU - Mitson, E.

AU - Chavier, I.

AU - Jacobson, K.

AU - Fill-houer, S.

AU - Shoberg, C.

AU - Michel, D.

AU - Estill, S.

AU - Hansen, J.

AU - Baumhover, M.

AU - Cauley, A. J.

AU - Kuller, H. L.

AU - Harper, L.

AU - Nasim, M.

AU - Orwoll, Eric

PY - 1994

Y1 - 1994

N2 - To test the hypothesis that estrogen replacement therapy preserves skin thickness, and to determine the relationship between bone mass and skin thickness, we performed a cross-sectional analysis of baseline data collected for a multicenter prospective study of osteoporotic fractures. 1,072 ambulatory nonblack women aged 65 years or older were recruited from population-based listings at two US clinical centers. Demographic and historical information and anthropometric measurements were obtained from a baseline questionnaire, interview, and examination. Estrogen use was assessed by questionnaire and interview. Skin thickness was measured over the middle metacarpophalangeal joint with mechanical calipers. Bone mass was measured by single photon absorptiometry at three appendicular sites: The distal and midradius, and the calcaneus. After adjusting for other potential confounding factors, each 10 years of age was associated with an 8.6% reduction in skin thickness, and every 5-kg/m2increase in body mass index was associated with a 3.8% increase in skin thickness. Smokers had thinner skin than nonsmokers. Estrogen users had thinner skin; compared to never-users, current users had a 5.1% reduction in skin thickness, and past users had a 2.0% reduction in skin thickness. Among estrogen users, every 10 years of use was associated with a 1.7% reduction in skin thickness. Skin thickness was weakly associated with bone mass of the middle radius and calcaneus, but not the distal radius. We found no evidence that estrogen preserves skin thickness; indeed, estrogen use is associated with thinner skin. Although skin thickness and bone mass are related, the association is too weak to be useful for predicting bone mass.

AB - To test the hypothesis that estrogen replacement therapy preserves skin thickness, and to determine the relationship between bone mass and skin thickness, we performed a cross-sectional analysis of baseline data collected for a multicenter prospective study of osteoporotic fractures. 1,072 ambulatory nonblack women aged 65 years or older were recruited from population-based listings at two US clinical centers. Demographic and historical information and anthropometric measurements were obtained from a baseline questionnaire, interview, and examination. Estrogen use was assessed by questionnaire and interview. Skin thickness was measured over the middle metacarpophalangeal joint with mechanical calipers. Bone mass was measured by single photon absorptiometry at three appendicular sites: The distal and midradius, and the calcaneus. After adjusting for other potential confounding factors, each 10 years of age was associated with an 8.6% reduction in skin thickness, and every 5-kg/m2increase in body mass index was associated with a 3.8% increase in skin thickness. Smokers had thinner skin than nonsmokers. Estrogen users had thinner skin; compared to never-users, current users had a 5.1% reduction in skin thickness, and past users had a 2.0% reduction in skin thickness. Among estrogen users, every 10 years of use was associated with a 1.7% reduction in skin thickness. Skin thickness was weakly associated with bone mass of the middle radius and calcaneus, but not the distal radius. We found no evidence that estrogen preserves skin thickness; indeed, estrogen use is associated with thinner skin. Although skin thickness and bone mass are related, the association is too weak to be useful for predicting bone mass.

KW - Bone mineral density

KW - Estrogen replacement therapy

KW - Skin thickness

UR - http://www.scopus.com/inward/record.url?scp=33745363017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745363017&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 131

EP - 136

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 3

ER -